Robotic Surgery
da Vinci systems, autonomous surgical robots, AI-assisted surgery.
The robotic surgery landscape has shifted from a single-platform market to a competitive ecosystem including the da Vinci SP and Xi, Medtronic Hugo RAS, CMR Versius, and Distalmotion Dexter, each with distinct ergonomics, modularity, and cost profiles. GCSA 2027 will benchmark these systems across urology, gynecology, colorectal, and head-and-neck surgery, with sessions on single-port transoral and transanal applications. The track also addresses AI-driven surgical scene understanding, automated skill assessment, telesurgery over 5G, and the regulatory and credentialing frameworks needed for safe scale-up.
- Multi-platform comparison: da Vinci SP/Xi, Hugo, Versius, Dexter
- Single-port robotics: transoral, transanal, and urologic applications
- AI for surgical phase recognition and automated skill assessment
- Telesurgery, 5G latency, and remote proctoring models
- Robotic credentialing, learning curves, and simulation-based training
- Cost-effectiveness and value-based adoption of robotic platforms
- Robotic hepatobiliary and pancreatic surgery: Whipple and beyond